News

23andMe Sold To Biotechnology Company For $256 Million
The acquisition comes two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
23andMe to Be Bought by Biotech Company for $256 Million
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...
Regeneron Pharmaceuticals to buy 23andMe for $256M
Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March ...
23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...
23andMe sold to biotech company Regeneron for $256 million
Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...
Genetic data will be safeguarded with 23andMe sale, drugmaker vows
The deal would put the DNA data of millions of customers in the hands of a pharmaceutical company, which hopes to supercharge ...
Explore more
Stock Movers: 23andMe, Reddit, Royal Caribbean
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
23andMe and its user data will soon belong to a pharmaceutical giant
23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech ...